Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP
Awesome product
A more recent Phase I safety trial on healthy volunteers was started in 2015 but puzzlingly, the researchers never published the results , and the trial record was marked completed with no data release
Before use, may be stored at room temperature for up to 4 weeks per prescribing information For multi-dose pens, patients should write the date of first use directly on the pen using a permanent marker to track how long the medication has been in use
Phase I: 3-12 months $75,000-$306,872 Phase II: 18-24 months $750,000-$2,000,000 Read solicitation instructions very carefully since these are subject to change and are different for each DOD Component Step 1: Pre-Release DOD announces new topics with a Pre-Release period